Capricor Therapeutics, Inc. (CAPR)

Capricor Therapeutics Revenue

In the year 2023, Capricor Therapeutics had annual revenue of $25.18M with 886.81% growth. Revenue in the quarter ending December 31, 2023 was $12.09M with 1,159.30% year-over-year growth.

• Revenue (ttm): $25.18M
• Revenue Growth: +886.81%
• P/S Ratio: 6.56
• Revenue / Employee: $249,288
• Employees: 101
• Market Cap: 165.08M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	25.18M	22.63M	886.81%
Dec 31, 2022	2.55M	2.31M	941.85%
Dec 31, 2021	244.90K	-65.35K	-21.06%
Dec 31, 2020	310.25K	-694.78K	-69.13%
Dec 31, 2019	1.01M	-666.33K	-39.87%
Dec 31, 2018	1.67M	-994.98K	-37.32%
Dec 31, 2017	2.67M	-1.33M	-33.32%
Dec 31, 2016	4.00M	-1.52M	-27.53%
Dec 31, 2015	5.52M	730.95K	15.27%
Dec 31, 2014	4.79M	4.28M	851.19%
Dec 31, 2013	503.23K	-1.40M	-73.50%
Dec 31, 2012	1.90M	544.26K	40.18%
Dec 31, 2011	1.35M	-	-
Dec 31, 2010	0	-	-
Dec 31, 2009	0	-	-
Dec 31, 2008	0	-	-
Dec 31, 2007	101.40K	-279.44K	-73.37%
Dec 31, 2006	380.84K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.